Osaka, Japan

Satoshi Hirabayashi

This inventor holds 1 USPTO granted patent. Top assignee: Astellas Pharma Gmbh. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Satoshi Hirabayashi. Retrieved from https://idiyas.com/inventor/satoshi-hirabayashi-h0kqfuki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Satoshi Hirabayashi: Innovator in Pharmaceutical Chemistry

Introduction

Satoshi Hirabayashi is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on piperazine derivatives. His expertise and dedication to research have led to advancements in medicinal chemistry.

Latest Patents

Hirabayashi holds a patent for a process related to the preparation of a piperazine derivative. The patent, titled "Process for the preparation of a piperazine derivative," specifically details the synthesis of (2R)-1-[3,5-bis(trifluoromethyl)benzoyl]-4-[2-[(2S)-2-(methoxymethyl)morpholino]ethyl]-2-(3-hydroxy-4-methylbenzyl)piperazine dihydrochloride. This compound is obtained by debenzylating (2R)-4-benzyl-1-[3,5-bis(trifluoromethyl)-benzoyl]-2-(3-hydroxy-4-methylbenzyl)piperazine, followed by N-alkylation and conversion to hydrochloride. Hirabayashi's innovative approach has resulted in a valuable addition to the pharmaceutical industry.

Career Highlights

Satoshi Hirabayashi is currently employed at Astellas Pharma GmbH, where he continues to contribute to the development of new pharmaceutical products. His work has been instrumental in advancing the company's research initiatives and enhancing its product offerings. With a focus on innovative solutions, Hirabayashi has established himself as a key player in the field.

Collaborations

Hirabayashi has collaborated with esteemed colleagues, including Keiichi Koga and Ryoki Orii. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, ultimately leading to groundbreaking advancements in their respective fields.

Conclusion

Satoshi Hirabayashi's contributions to pharmaceutical chemistry, particularly through his patent on piperazine derivatives, highlight his innovative spirit and dedication to research. His work at Astellas Pharma GmbH and collaborations with fellow researchers underscore the importance of teamwork in driving scientific progress. Hirabayashi's achievements serve as an inspiration for future inventors in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…